Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …
News
800px-smallpox_vaccine

WHO reports “alarming decline” in child vaccinations due to COVID-19 disruption

July 17, 2020 Medical Communications, Sales and Marketing COVID-19, WHO, vaccination, vaccines

The World Health Organization and UNICEF have pointed to an “alarming decline” in the levels of children worldwide receiving essential …
News
fda

FDA grants fast review for Bayer and MSD’s heart failure drug vericiguat

July 17, 2020 Medical Communications Bayer, FDA, MSD

The FDA has granted a fast Priority Review for Bayer and MSD’s heart failure drug vericiguat. This was based on …
News
remsssy

Hydroxychloroquine proves ineffective against COVID-19 in newest trial

July 17, 2020 Medical Communications COVID-19, coronavirus, hydroxychloroquine

The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients. A recent study was published in the …
News
top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

July 17, 2020 Medical Communications top 10

The news this week as usual centres on treatments and vaccines for COVID-19, with Russia claiming it is the first …
News
Doctor online

COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest

July 16, 2020 Medical Communications, Research and Development digital, healthcare, pharma

The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …
News
edwin

Dr Edwin Moses appointed as Chairman of the Board of Sensorin

July 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sensorin have appointed Dr Edwin Moses as the Chairman of its Board of Directors Moses joins from his previous role …
Appointment
shutterstock_159488225

New data shows Gilead’s remdesivir “potently inhibited” SARS-CoV-2 in human lung cell cultures

July 10, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

New findings published from researchers at Vanderbilt University Medical Center (VUMC) at the University of North Carolina, as well as …
News
brain

Scientists warn of brain damage linked to COVID-19

July 10, 2020 Medical Communications COVID-19, Neurological, coronavirus

COVID-19 could lead to a wave of brain damage in people who were infected with the virus. Experts at the …
News
shutterstock_gonnorrhea

Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance

July 10, 2020 Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma

Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
News
world

The World Health Organization says COVID-19 can linger in the air indoors

July 10, 2020 Medical Communications COVID, COVID-19, WHO, coronavirus

The World Health Organization has recoginised that COVID-19 can be transmitted indoors by droplets in the air, reversing its previous …
News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 10, 2020 Medical Communications coronavirus, covid19, top 10

The World Health Organization features prominently in the news this week, as it discontinued trials into the viability of hydroxychloroquine, …
News
european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020 Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …
News
racism_protests

US anti-racism protests did not cause spike in coronavirus cases, new study shows

July 3, 2020 Medical Communications COVID-19, coronavirus

Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according …
News
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020 Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026